Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services provides stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through equipment leasing and direct patient care services. Company news commonly covers quarterly results, procedure and treatment volumes, Gamma Knife sites, LINAC centers, proton beam radiation therapy leases, and the expansion of stand-alone radiation therapy treatment centers in the United States and Latin America.
Updates also address health system partnerships, revenue mix between leasing and direct patient services, equipment upgrades such as Gamma Knife platform improvements, and operating activity at centers including Rhode Island and Puebla, Mexico.
American Shared Hospital Services (NYSE American: AMS) announced an expansion of its sales efforts to include federal healthcare facilities in the U.S., encompassing Veterans Affairs (VA) and Department of Defense (DoD) hospitals. This initiative follows a partnership with Growth Strategies in Motion (GSM) to enhance business development services. With $8.4 million in cash and a $7 million line of credit, AMS aims for sustained profitability. The company is known for its Gamma Knife radiosurgery equipment and advanced radiation therapy solutions.
American Shared Hospital Services (AMS) reported a 12.2% increase in Q2 revenue, totaling $4.48 million. Proton therapy revenue rose 10.6%, driven by higher reimbursements, while Gamma Knife revenue grew 13% due to increased treatment volumes. Operating income improved to $352,000 from a loss of $570,000 last year. Despite a net loss of $87,000, net income excluding debt extinguishment stood at $157,000, or $0.03 per diluted share. Cash reserves reached $8.4 million, providing a solid foundation for future growth.
American Shared Hospital Services (NYSE American: AMS) will host a quarterly conference call on August 12, 2021, at 3:00 PM EST to discuss its second quarter 2021 financial results. The press release with financial details will be issued premarket on the same day. Participants can join by calling 1 (877) 317-6789 or via webcast on the company's website. American Shared Hospital Services specializes in advanced radiation therapy equipment and solutions, including Gamma Knife radiosurgery and proton therapy.
American Shared Hospital Services (AMS) reported breakeven results for Q1 2021, with revenues of $4.36 million, a 4.5% decline year-over-year. Proton therapy revenue fell by 8.7% to $1.53 million, while Gamma Knife revenue remained stable at $2.89 million. The company achieved an operating income of $90,000, a turnaround from a loss in the prior year. Net income was $29,000 compared to a net loss of $135,000 in Q1 2020. AMS improved its balance sheet, achieving positive working capital of $4.2 million and reducing debt obligations by approximately $5.9 million.
American Shared Hospital Services (AMS) will hold a quarterly conference call on May 13, 2021, at 1:00 PM EST to discuss its first quarter 2021 financial results. The press release detailing these results will be published premarket on the same day. AMS is known for advancing technology solutions in stereotactic radiosurgery and advanced radiation therapy. The company specializes in Gamma Knife radiosurgery and offers other cutting-edge treatment systems. For further details, visit www.ashs.com.
American Shared Hospital Services (NYSE American: AMS) announced its Annual Meeting of Shareholders will be held virtually on June 25, 2021, at 8:00 a.m. PST due to the COVID-19 pandemic. April 26, 2021, is set as the record date for determining shareholders entitled to vote. The company specializes in providing advanced technology solutions for stereotactic radiosurgery and radiation therapy, including Gamma Knife and proton therapy systems. The press release also includes a safe harbor statement discussing potential risks such as market conditions and financial variability.
American Shared Hospital Services (AMS) has secured a $22 million credit agreement with Fifth Third Bank, closing on April 9, 2021. The agreement comprises three loan facilities: a $9.5 million term loan for refinancing Gamma Knife debt and future projects, a $5.5 million term loan for PBRT Orlando equipment debt and working capital, and a $7 million revolving line of credit for increased project negotiation flexibility. This financing aims to lower costs, enhance cash generation, and support AMS's growth strategy in the advanced radiation therapy market.
American Shared Hospital Services (NYSE American: AMS) reported Q4 2020 revenues of $4,608,000, a 3.7% decrease from Q4 2019. Proton therapy revenue fell to $1,403,000 (-5.6%), while Gamma Knife revenue decreased slightly by 0.8% to $3,205,000. Operating loss was $8,543,000, markedly down from a profit a year earlier, largely due to an $8,264,000 asset impairment charge. Net loss increased to $6,231,000 from a profit of $193,000 in Q4 2019. Despite these challenges, CEO Ray Stachowiak indicated plans for growth and operational recovery in 2021, with a stronger cash position of $4.3 million.
American Shared Hospital Services (NYSE American: AMS) reported Q3 2020 financials, revealing total revenue of $4,670,000, down 11.9% year-over-year but up 17.0% from Q2 2020. Proton therapy revenue remained flat year-over-year at $1,687,000, while Gamma Knife revenue decreased 9.9% to $2,983,000. The company experienced a net loss of $209,000, contrasting with a net income of $165,000 in Q3 2019. Notably, cash reserves increased to $3.6 million. The CEO highlighted a focus on expense management and potential growth in revenue streams.
American Shared Hospital Services (NYSE American: AMS) announced a quarterly conference call scheduled for November 12, 2020, at 3:00 pm EST. The call will discuss the company’s financial results for the third quarter of 2020, which will be released premarket on the same day. Interested parties can participate by calling 1 (888) 466-9845 and entering passcode 6465095#. The event will also be available via a simultaneous webcast on the company's website. A replay will be accessible until November 26, 2020.